BJDX Bluejay Diagnostics, Inc.

NASDAQ
$0.91

Bluejay Diagnostics, Inc. (BJDX) Institutional Ownership

What the institutions did with BJDX last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers reporting
11
filed a 13F this quarter
Managers holding
8
+2 on the quarter
Buyers
6
5 opened new
Sellers
4
3 sold out entirely
Buyer share
60.0%
of managers who traded it
Breadth
+20.0
net buyers, as a share of those trading

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
ARMISTICE CAPITAL, LLC 131.0K 60.6%
HEIGHTS CAPITAL MANAGEMENT, INC 35.4K 16.4%
BOOTHBAY FUND MANAGEMENT, LLC 27.1K 12.6%
BANK OF AMERICA CORP /DE/ 10.3K 4.8%
VANGUARD FIDUCIARY TRUST CO 10.2K 4.7%
Tower Research Capital LLC (TRC) 1.9K 0.9%
L1 Global Manager Pty Ltd 120 0.1%
Caitong International Asset Management Co., Ltd 1 0.0%

Largest changes

Manager Action Previous Current Change
ARMISTICE CAPITAL, LLC New 0 131.0K +131.0K
HEIGHTS CAPITAL MANAGEMENT, INC New 0 35.4K +35.4K
SABBY MANAGEMENT, LLC Sold Out 28.7K 0 -28.7K
GEODE CAPITAL MANAGEMENT, LLC Sold Out 28.1K 0 -28.1K
BOOTHBAY FUND MANAGEMENT, LLC New 0 27.1K +27.1K
BANK OF AMERICA CORP /DE/ New 0 10.3K +10.3K
VANGUARD FIDUCIARY TRUST CO New 0 10.2K +10.2K
Tower Research Capital LLC (TRC) Increased 1.7K 1.9K +178
UBS Group AG Sold Out 124 0 -124
Caitong International Asset Management Co., Ltd Reduced 3 1 -2

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.